Navigation Links
Osteoporosis Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Date:10/25/2011

>Table 25: Effect of Evista on Increases in BMD vs. Placebo 73

Table 26: Effect of Forteo on Risk of Vertebral Fractures in Postmenopausal Women with Osteoporosis 76

Table 27: Mean Percentage Change in BMD in Postmenopausal Women with Osteoporosis 76

Table 28: Osteoporosis Therapeutics Market, Phase III and Regulatory Filed Pipeline, 2011 84

Table 29: Osteoporosis Therapeutics Market, Phase II Pipeline, 2011 85

Table 30: Osteoporosis Therapeutics Market, Phase I Pipeline, 2011 86

Table 31: Osteoporosis Therapeutics Market, Pre-clinical and Discovery Phase Pipeline, 2011 87

Table 32: Osteoporosis Therapeutics Market, Global, Most Promising Drugs in Clinical Development, 2011 90

Table 33: Osteoporosis Therapeutics, Global, Clinical Trials, 2011 102

Table 34: Osteoporosis Therapeutics, Global, Clinical Trials by Phase, 2011 103

Table 35: Osteoporosis Therapeutics, Global, Clinical Trials by Status of Development, 2011 104

Table 36: Osteoporosis Therapeutics, Global, Prominent Sponsors, 2011 105

Table 37: Osteoporosis Therapeutics, Global, Overall Sponsors, 2011 106

Table 38: Osteoporosis Therapeutics, Global, Top Ten Companies by Phase, 2011 107

Table 39: Amgen Inc.– Osteoporosis Pipeline, 2011 114

Table 40: Astellas Pharma, Inc. – Osteoporosis Pipeline, 2011 116

Table 41: EffRx, Inc. – Osteoporosis Pipeline, 2011 117

Table 42: Merck & Co., Inc.– Osteoporosis Pipeline, 2011 118

Table 43: Novartis AG – Osteoporosis Pipeline, 2011 120

Table 44: Osteologix,Inc. – Osteoporosis Pipeline, 2011 121

Table 45: Pfizer Inc. .– Osteoporosis Pipeline, 2011 125

Table 46: Radius Health Inc. – Osteoporosis Pipeline, 2011 126

Table 47: Tarsa Inc. – Osteoporosis Pipeline, 2011 126

Table 48: ZydusCadila Inc. – Osteoporosis Pipeline, 2011 129

Table 49: Osteopor
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Zosano Pharma, Inc. and Asahi Kasei Pharma Corporation Enter Exclusive Licensing Agreement for a Weekly Transdermal Patch Formulation of Teribone™ (teriparatide acetate) for Osteoporosis
2. Womens Health Therapeutics, Analysis and Market Forecasts to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in the Menopause and Osteoporosis Markets
3. Tarsa Therapeutics Presents Positive Efficacy and Safety Data Comparing Its Oral Calcitonin to Nasal Calcitonin and Placebo in Phase III Osteoporosis Treatment Trial
4. Lilly Announces Review of Data on Long-Term Raloxifene Treatment for Postmenopausal Osteoporosis Published in Current Medical Research & Opinion
5. Radius, 3M Drug Delivery Systems Sign Development Agreement for Transdermal Delivery of BA058 for Treatment of Osteoporosis
6. Amgen and UCB Announce Positive Phase 2 Results of AMG 785/CDP7851 in Patients With Postmenopausal Osteoporosis (PMO)
7. Tarsa Therapeutics Reports Positive Top-Line Results From Pivotal Phase III ORACAL Trial of its Oral Calcitonin in Treatment of Postmenopausal Osteoporosis
8. ICAP Ocean Tomo Announces Patents for a New and Safer Method of Treatment of Osteoporosis and Tumor Metastasis Using a Novel Zoledronic Acid Combination
9. Commonly Prescribed Osteoporosis Drug Associated with Very Low Risk of Serious Jaw Disease
10. Tarsa Therapeutics Completes Phase III Trial of its Oral Calcitonin for Treatment of Postmenopausal Osteoporosis and Initiates Phase II Trial in Osteoporosis Prevention
11. $1,700,000 Funding of NeoStems Very Small Embryonic-Like Stem Cells Being Developed to Treat Osteoporosis Recommended by the Department of Defense Peer Reviewed Medical Research Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... May 22, 2015 /CNW/ - More than fifty years ago, ... morning sickness in expectant mothers. Tragically, Thalidomide caused serious and ... Support has been provided to survivors over ... Canada in 1991 and settlements from ... a legal obligation to provide support, we have a clear ...
(Date:5/22/2015)... , May 22, 2015 Electrophysiologist ... Institute recently traveled to Boston, MA ... at the 2015 Heart Rhythm Society conference. These ... to focus on the ideas, people and technology ... Convergent is a hybrid, minimally invasive cardiac operation ...
(Date:5/22/2015)... NEW YORK , May 22, 2015 /PRNewswire/ ... approval of Zarxio (filgrastim-sndz) -- the first biosimilar ... -- points toward growth in the ... Information. The mainstream CMO industry is geared to ... infrastructure to produce major biopharmaceutical products. The healthcare ...
Breaking Medicine Technology:Statement from Minister Ambrose on Thalidomide 2Statement from Minister Ambrose on Thalidomide 3St. Joseph's Hospital Heart Institute Physician Presents at Heart Rhythm Society 2St. Joseph's Hospital Heart Institute Physician Presents at Heart Rhythm Society 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 4
... 1, 2012  PDI, Inc. (Nasdaq: PDII ) ... and full year 2011 financial results on Wednesday, March ... conference call on Thursday, March 8, at 8:30 am ... March 8, 2012Time:8:30 am Eastern timeDial-in numbers:(866) 644-4654 (U.S. ...
... therapies for foot wounds are saving limbs, restoring mobility, ... who suffer from non-healing foot ulcers. "For ... wounds can be a tremendous problem, making these advanced ... clinical professor of surgery at Yale School of Medicine. ...
Cached Medicine Technology:Advanced Treatments Help Hard-to-Heal Diabetic Foot Ulcers—and Improve Lives 2Advanced Treatments Help Hard-to-Heal Diabetic Foot Ulcers—and Improve Lives 3
(Date:5/23/2015)... Injury lawyer Steven H. Heisler commented today on the ... legislature but which has not been signed to date by ... 449 with overwhelming bipartisan support on April 10, 2015, ... This bill ensures that fracking is prohibited in Maryland through ... of fracking to our water supplies and the air we ...
(Date:5/22/2015)... 22, 2015 The American College of ... in June. They will hold a webinar on the ... two-day class on Classical Chinese Medicine. , Webinar – ... Steve Given, the Dean of Clinical Education, will lead ... First Professional Doctorate program. ACTCM is currently developing this ...
(Date:5/22/2015)... May 22, 2015 Hundreds of ... behalf of individuals who allegedly experienced serious internal ... continue to move forward in the U.S. District ... Pretrial Order dated May 4, 2015, the Court ... and electronically stored information. Among other things, the ...
(Date:5/22/2015)... Combination therapy, or polytherapy, will likely ... pulmonary disorder (COPD) as the dominant companies like ... well as Germany’s Boehringer Ingelheim compete with each ... market payers, clinicians and patients be disposed to ... new ones? , In spite of recently approved ...
(Date:5/22/2015)... Family, friends, students, colleagues, mentors and fellow physicians ... D. Leffall, on Monday, May 18, with an 85th ... in the hospital’s Tower Auditorium. Leffall’s younger sister, 83-year-old ... to keep the secret. “I’d like to go in ... know something is up,” she said. , After more ...
Breaking Medicine News(10 mins):Health News:Baltimore Attorney Urges Governor Hogan to Sign the Fracking Moratorium Bill 2Health News:Baltimore Attorney Urges Governor Hogan to Sign the Fracking Moratorium Bill 3Health News:ACTCM Announces Upcoming June Events 2Health News:Court Overseeing Federal Xarelto Lawsuits Establishes Procedures Governing Preservation of Documents, Electronically Stored Information 2Health News:Court Overseeing Federal Xarelto Lawsuits Establishes Procedures Governing Preservation of Documents, Electronically Stored Information 3Health News:Court Overseeing Federal Xarelto Lawsuits Establishes Procedures Governing Preservation of Documents, Electronically Stored Information 4Health News:Chronic Obstructive Pulmonary Disorder Therapeutics Market Discussed in In-demand FirstWord Report Published at MarketPublishers.com 2Health News:Colleagues Surprise Dr. LaSalle Leffall with 85th Birthday Celebration 2
... Other Providers Would Likely Demand Similar,Treatment Next Year, ... released a new ad today warning policymakers,that other Medicare ... the "same prompt-pay deal" next year if Congress requires,pharmacists ... "Paying one group of Medicare providers twice as ...
... Older people are especially,at risk from heat-related health problems such ... currently experiencing, now is not,the time to do chores, run ... for all ages, but potentially life threatening,for older persons," according ... 10 tips for dealing with a heat wave:, 1. ...
... The 125,000-member American College of Physicians (ACP) today ... the Medicare Improvements for Patients and Providers Act of ... S. 3101 because it addresses and incorporates three of ... MD, FACP, wrote Senator Max Baucus (D-MT), chairman of ...
... June 9 Mylan Inc. (NYSE: MYL ),today ... from the U.S. Food and Drug Administration (FDA) for ... mg and 10,mg., Zaleplon Capsules are the generic ... of approximately $88 million for,the 12 months ending March ...
... donates $100,000 to American Red Cross, INDIANAPOLIS, June ... of Eli Lilly and Company (NYSE: LLY ), ... to aid,Indiana tornado and flood victims. More than 44 ... Mitch Daniels as a result of deadly,tornadoes and severe ...
... MADISON, N.J., June 9 Wyeth (NYSE: ... the Goldman Sachs Twenty-Ninth,Annual Global Healthcare Conference on ... for Wyeth will be Bernard Poussot, President and ... webcast live for investors at, http://www.wyeth.com and ...
Cached Medicine News:Health News:New PCMA Ad: Pharmacist 'Prompt Pay' Will Trigger 'Domino Effect' Among Other Medicare Providers 2Health News:How Seniors Can Beat the Heat 2Health News:ACP pledges support for Medicare improvements for Patients and Providers Act of 2008 2Health News:Lilly to Provide Aid to Indiana Tornado and Flood Victims 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: